The Hartford Healthcare Fund

The Hartford Healthcare Fund reported 87 holdings worth US$772M as of Jul 31, 2026 (Form N-PORT)

As of Jul 31, 2026 · Filed Sep 29, 2026

The Hartford Healthcare Fund reported 87 holdings worth US$772M as of Jul 31, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Merck & Company, Inc. Filed Sep 29, 2026 (Form N-PORT).

Holdings
87
Value as reported
US$772M

The filing in full

CompanySharesValue as reported% of portfolio
Eli Lilly And Company80,883US$92.9M12.0%
Johnson & Johnson203KUS$52.1M6.7%
Merck & Company, Inc.356KUS$46.3M6.0%
Unitedhealth Group Incorporated88,244US$36.6M4.7%
Abbvie Inc.130KUS$32.5M4.2%
Elevance Health, Inc.61,615US$23.2M3.0%
Intuitive Surgical, Inc.62,861US$22.2M2.9%
Cvs Health Corporation210KUS$21.9M2.8%
Vertex Pharmaceuticals Incorporated42,701US$20.4M2.6%
Danaher Corporation102KUS$19.9M2.6%
Edwards Lifesciences Corporation223KUS$19.2M2.5%
Cencora, Inc.61,017US$19M2.5%
Regeneron Pharmaceuticals, Inc.20,444US$15.6M2.0%
Hca Healthcare, Inc.36,047US$14.5M1.9%
Boston Scientific Corporation310KUS$14.5M1.9%
Abbott Laboratories133KUS$14.1M1.8%
Thermo Fisher Scientific Inc21,279US$12.2M1.6%
Agilent Technologies, Inc.85,848US$11.9M1.5%
Amgen Inc.27,841US$10.7M1.4%
Biogen Inc.51,870US$10.5M1.4%
Stryker Corporation29,293US$9.54M1.2%
Gsk Plc347KUS$9.01M1.2%
Medtronic Plc.102KUS$8.67M1.1%
Centene Corporation136KUS$8.48M1.1%
Dexcom, Inc.93,874US$7.83M1.0%
Incyte Corporation61,086US$7.3M0.95%
Cardinal Health, Inc.30,813US$7.09M0.92%
United Therapeutics Corporation13,024US$6.74M0.87%
Steris Plc (ireland)28,649US$6.54M0.85%
Ucb S.a.23,685US$6.08M0.79%
Astrazeneca Plc35,800US$6.07M0.79%
Ascendis Pharma A/s23,901US$5.83M0.75%
Bristol-myers Squibb Company88,181US$5.76M0.75%
Elanco Animal Health Incorporated215KUS$5.67M0.73%
Cytokinetics, Incorporated72,039US$5.56M0.72%
Madrigal Pharmaceuticals, Inc.11,677US$5.46M0.71%
Ionis Pharmaceuticals, Inc.104KUS$5.39M0.70%
Galderma Group Ag24,060US$5.24M0.68%
Alnylam Pharmaceuticals, Inc.24,864US$5.11M0.66%
Revolution Medicines, Inc.26,888US$5.04M0.65%
Protagonist Therapeutics, Inc.35,155US$4.8M0.62%
Ptc Therapeutics, Inc.68,186US$4.64M0.60%
Heartflow, Inc.182KUS$4.59M0.59%
Bridgebio Pharma, Inc.57,222US$4.58M0.59%
Arcus Biosciences, Inc.160KUS$4.52M0.59%
Disc Medicine, Inc.55,907US$4.3M0.56%
Argenx Se4,871US$4.16M0.54%
Encompass Health Corporation37,246US$4.14M0.54%
Pharvaris N.v.123KUS$4.03M0.52%
Kymera Therapeutics, Inc.38,652US$4M0.52%
Celldex Therapeutics, Inc.105KUS$3.99M0.52%
Dianthus Therapeutics, Inc.37,237US$3.98M0.52%
Scholar Rock Holding Corporation77,842US$3.68M0.48%
Adaptive Biotechnologies Corporation160KUS$3.61M0.47%
Option Care Health, Inc.151KUS$3.48M0.45%
Zenas Biopharma, Inc.109KUS$3.42M0.44%
Mirum Pharmaceuticals, Inc.31,231US$3.31M0.43%
Vaxcyte, Inc.58,543US$3.17M0.41%
Qiagen N.v.74,691US$3.09M0.40%
Immunome, Inc.136KUS$3.09M0.40%
Cg Oncology, Inc.40,863US$2.91M0.38%
Trevi Therapeutics, Inc.156KUS$2.84M0.37%
Inspire Medical Systems, Inc.51,992US$2.61M0.34%
Stoke Therapeutics, Inc.89,171US$2.57M0.33%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A305KUS$2.32M0.30%
Kailera Therapeutics, Inc.133KUS$2.26M0.29%
Moderna, Inc.40,629US$2.23M0.29%
Definium Therapeutics, Inc.49,500US$2.15M0.28%
Dyne Therapeutics, Inc.85,300US$2.15M0.28%
Genfleet Therapeutics (shanghai), Inc. Class H584KUS$2.06M0.27%
Alignment Healthcare, Inc.131KUS$1.94M0.25%
Icon Plc11,852US$1.94M0.25%
Avalyn Pharma Inc.17,700US$510K0.07%
Alebund Pharmaceuticals (jiangsu) Limited Class H85,600US$297K0.04%
Alamar Biosciences, Inc.9,100US$231K0.03%
Oculis Holding Ag0US$00.00%
Nuvalent, Inc.0US$00.00%
Crinetics Pharmaceuticals, Inc.0US$00.00%
Natera, Inc.0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
Mineralys Therapeutics, Inc.0US$00.00%
Avantor, Inc.0US$00.00%
Bio-techne Corp0US$00.00%
Xenon Pharmaceuticals Inc.0US$00.00%
Viridian Therapeutics, Inc.0US$00.00%
Acadia Healthcare Company, Inc.0US$00.00%
Newamsterdam Pharma Company N.v.0US$00.00%

Source

View original at SEC

Related